An in-depth look to EXPRES2ION BIOTECH HOLDING AB operating, investing, and financing activities

EXPRS2 free cash flow for Q3 24 is -16.73 M SEK. For 2023, EXPRS2 free cash flow was -102.9 M SEK and operating cash flow was -100.89 M SEK.